Intuitive Surgical Sought Ninth Circuit Rehearing

The company challenged a recent panel decision regarding antitrust claims in the robot-assisted surgical sector.

Updated on Sept. 28, 2026 in Healthcare

Bold flat-color editorial illustration showing a symbolic robotic surgical arm in red and cream, representing complex antitrust legal proceedings.
Intuitive Surgical has petitioned the Ninth Circuit for an en banc rehearing to challenge a panel ruling regarding antitrust claims in the robotic surgery market. AI Illustration. Upload story photo >

Live Poll

Should companies face antitrust liability for restricting third-party components in their proprietary systems?

Intuitive Surgical has petitioned the Ninth Circuit for an en banc rehearing following a three-judge panel ruling. The previous decision revived antitrust claims brought by Surgical Instrument Service Co.

Why it matters

Intuitive Surgical contends that the panel's ruling improperly penalizes the company for its success in the robotic surgery market. The outcome of this appeal could set a major precedent for antitrust liability regarding aftermarket product approval processes.

The petition follows an appellate ruling that a plaintiff can establish a single-brand aftermarket by proving market power in a foremarket.

The players

Intuitive Surgical

This company develops, manufactures, and markets robotic systems for minimally invasive surgery.

Surgical Instrument Service Co.

This entity provides third-party repair and maintenance services for various surgical instruments and systems.

Ninth Circuit

This is a United States Court of Appeals that hears cases from federal district courts in the western United States.

The details

The dispute centers on allegations that Intuitive Surgical's approval process for third-party products creates potential antitrust liability. The company is seeking to overturn the panel's decision which allowed the case brought by Surgical Instrument Service Co. to proceed.

Timeline

  1. Intuitive Surgical filed the petition for a rehearing on September 28, 2026.

Market Landscape

This litigation highlights ongoing friction between manufacturers and independent service providers over aftermarket ecosystems. It tests the extent to which proprietary product approvals can be considered exclusionary under current antitrust standards.

The final ruling may eventually influence the availability and cost of third-party repair services for advanced medical hardware. If antitrust scrutiny increases, hospitals and clinics might see more competitive options for maintaining their surgical equipment.

The takeaway

Legal battles over aftermarket repairs often hinge on how companies define their product ecosystems. Businesses looking to protect their internal systems may face increased legal hurdles if appellate courts continue to favor expanded aftermarket competition.

Further reading

For more background on the sector, visit the Healthcare section.

Source note: This article includes information reported by Mlex.

Live Poll

Should companies face antitrust liability for restricting third-party components in their proprietary systems?